|
|
Volumn 139, Issue 4, 2006, Pages 455-459
|
|
Operative trials: the opportunity beckons-an update on the American College of Surgeons Oncology Group
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
CETUXIMAB;
CISPLATIN;
DOCETAXEL;
ETOPOSIDE;
EXEMESTANE;
FLUOROURACIL;
IMATINIB;
LETROZOLE;
MELPHALAN;
RECOMBINANT ALPHA INTERFERON;
RECOMBINANT TUMOR NECROSIS FACTOR;
TAMOXIFEN;
BONE MARROW METASTASIS;
BRACHYTHERAPY;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CHONDROSARCOMA;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DUCTAL CARCINOMA IN SITU;
ESOPHAGUS CARCINOMA;
GASTROINTESTINAL STROMAL TUMOR;
HEAD AND NECK CARCINOMA;
HUMAN;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAL SOCIETY;
MELANOMA;
META ANALYSIS;
MOUTH CARCINOMA;
ONCOLOGY;
PANCREAS ADENOCARCINOMA;
PARTIAL MASTECTOMY;
PATIENT CARE;
PATIENT PARTICIPATION;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
RADIOFREQUENCY ABLATION;
RECTUM CANCER;
RETROPERITONEAL SARCOMA;
REVIEW;
SQUAMOUS CELL CARCINOMA;
SURGEON;
SYSTEMATIC REVIEW;
CLINICAL TRIALS;
HUMANS;
NEOPLASMS;
SOCIETIES, MEDICAL;
SURGICAL PROCEDURES, OPERATIVE;
UNITED STATES;
|
|
EID: 33646032060
PISSN: 00396060
EISSN: None
Source Type: Journal
DOI: 10.1016/j.surg.2005.08.008 Document Type: Review |
|
Times cited : (7)
|
|
References (3)
|
